P. A. F. KALPAKLIOĞLU, & P. A. BAÇÇIOĞLU (2018). Response to omalizumab in urticaria and asthma: is it a lifetime togather treatment?. *European Medical Journal*, 3(1), 76–78.
Dergi: European Medical Journal | Yıl: 2018 | Cilt/Sayı: 3/1 | Sayfa: 76-78 | Yazarlar: KALPAKLIOĞLU AYŞE FÜSUN,BAÇÇIOĞLU AYŞE,Cerit Ahu
Co-authorship network among authors
Collaboration links among KKU authors of this publication.
Loading co-author network...
No co-author data
Not enough KKU author records for this publication.
Shared publications
Other publications by authors
Other academic outputs by the same KKU authors — newest first.
İlgili yayınlar yükleniyor…
İlgili yayın bulunamadı.
AI Assistant
Online
Command LibraryPick a ready command or type your own question
System architect
Tahsin BALCI
Kırıkkale University · IT Department · Programmer
KU Career Ecosystem Software development IT operations
Architect and developer of the KU Career Ecosystem. Designs and builds this system at the IT Department to present staff, publication and unit data under one roof.
